Microbial Genomics and Bioprocessing Research Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
Programs and Projects
Subjects of Investigation
 

Title: PHYLOGENETIC DIVERSITY OF MEDICALLY IMPORTANT FUSARIA

Authors
item O Donnell, Kerry
item Rinaldi, M - UTHSC, SAN ANTONIO TX
item Sutton, D - UTHSC, SAN ANTONIO TX
item Fothergill, A - UTHSC, SAN ANTONIO TX
item Summerbell, R - CBS UTRECHT NTHRLNDS
item Padhye, A - CDC, ATLANTA, GA
item Zhang, N - PENNSYLVANIA STATE UNIV
item Geiser, D - PENNSYLVANIA STATE UNIV

Submitted to: Meeting Abstract
Publication Type: Abstract
Publication Acceptance Date: May 25, 2003
Publication Date: N/A

Technical Abstract: Due to the paucity of phenotypic traits, morphological species recognition greatly underestimates the number of clinically important species of the opportunistic filamentous ascomycete Fusarium. To address this problem, species limits are being investigated using multilocus DNA sequence data, using a genealogical concordance version of phylogenetic species recognition. Phylogenetic analyses indicate that most isolates from infected humans and other animals fall within one of three large species complexes (F. solani, F. oxysporum and F. moniliforme/ Gibberella fujikuroi). Understanding the genetic diversity and species boundaries within each of these complexes should provide valuable tools for molecular epidemiological studies focused on tracing the environmental sources of these opportunistic molds. Ongoing research is directed at expanding this database to reflect the global genetic diversity of Fusarium. To illustrate the utility of this multilocus DNA sequence database, fusaria isolated from infected patients are compared with hospital environmental samples to address the following question: Are the species most commonly isolated from humans conspecific with the ones most prevalent within a hospital environment? Lastly, accurate knowledge of species limits of the fusaria may prove to be an important component of therapy since species may respond differently to antifungal drugs.

   
 
 
Last Modified: 05/13/2009
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House